The Weekly Litigation News Digest is now live. Subscribe now

Treatment Of Sepsis And Septic Shock - EP3781210

The patent EP3781210 was granted to Combioxin on Aug 7, 2024. The application was originally filed on Apr 18, 2019 under application number EP19717944A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3781210

COMBIOXIN
Application Number
EP19717944A
Filing Date
Apr 18, 2019
Status
Granted And Under Opposition
Jul 5, 2024
Publication Date
Aug 7, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLERMay 6, 2025BRAND MURRAY FULLERADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2013186286
DESCRIPTIONWO2017216282
INTERNATIONAL-SEARCH-REPORTWO2013186286
INTERNATIONAL-SEARCH-REPORTWO2017216282
OPPOSITIONUS8906855
OPPOSITIONUS9439855
OPPOSITIONWO2013186286
OPPOSITIONWO2017222912
OTHERUS8906855
OTHERUS9439855
OTHERWO2017222912

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents